ReGenX Biosciences, LLC

Organization

New York, NY, US

Ticker Symbols

NASDAQ:RGNX

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Address
9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
Mailing Address
9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
State Location
MD
State of Incorporation

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Treatment of mucopolysaccharidosis II with recombinant human iduron...
- Patent number 11,986,515
- Issue date May 21, 2024
- REGENXBIO Inc.
- Stephen Joseph Pakola
- G01 - MEASURING TESTING
Information Patent Grant
Treatment of mucopolysaccharidosis II with recombinant human iduron...
- Patent number 11,613,739
- Issue date Mar 28, 2023
- REGENXBIO Inc.
- Stephen Yoo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods to treat mucopolysaccharide type I or deficiency in alpha-L...
- Patent number 9,827,295
- Issue date Nov 28, 2017
- Regents of The University of Minnesota
- R. Scott McIvor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
METHOD OF PRODUCING A RECOMBINANT VIRUS PARTICLE
- Publication number 20240167054
- Publication date May 23, 2024
- Regenxbio Inc.
- Robert STADELMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VECTORIZED ANTI-CGRP AND ANTI-CGRPR ANTIBODIES AND ADMINISTRATION T...
- Publication number 20240124890
- Publication date Apr 18, 2024
- Regenxbio Inc.
- Jared Smith
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...
- Publication number 20240117328
- Publication date Apr 11, 2024
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INJECTION OF SINGLE-STRANDED OR SELF-COMPLEMENTARY ADENO-ASSOCIATED...
- Publication number 20240108761
- Publication date Apr 4, 2024
- Emory University
- Anthony Donsante
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ADENO-ASSOCIATED VIRUS VECTOR PHARMACEUTICAL COMPOSITION AND METHODS
- Publication number 20240108669
- Publication date Apr 4, 2024
- Regenxbio Inc.
- Tristan Marshall
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES
- Publication number 20240091380
- Publication date Mar 21, 2024
- Regenxbio Inc.
- Marie-Laure Nevoret
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMPROVED PRODUCTION OF RECOMBINANT POLYPEPTIDES AND VIRUSES
- Publication number 20240084329
- Publication date Mar 14, 2024
- Regenxbio Inc.
- Michael GILLMEISTER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...
- Publication number 20240058426
- Publication date Feb 22, 2024
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED...
- Publication number 20240050537
- Publication date Feb 15, 2024
- Regenxbio Inc.
- Stephen Yoo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FORMULATIONS FOR SUPRACHOROIDAL ADMINISTRATION SUCH AS HIGH VISCOSI...
- Publication number 20240024508
- Publication date Jan 25, 2024
- Regenxbio Inc.
- Jared Bee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING EPILEPSY
- Publication number 20240018524
- Publication date Jan 18, 2024
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Valérie CREPEL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FORMULATIONS FOR SUPRACHOROIDAL ADMINISTRATION SUCH AS GEL FORMULAT...
- Publication number 20230414788
- Publication date Dec 28, 2023
- Regenxbio Inc.
- Jared Bee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VECTORIZED ANTI-TNF-ALPHA ANTIBODIES FOR OCULAR INDICATIONS
- Publication number 20230391864
- Publication date Dec 7, 2023
- REGENXBIO, Inc.
- Xu Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VECTORIZED FACTOR XII ANTIBODIES AND ADMINISTRATION THEREOF
- Publication number 20230390418
- Publication date Dec 7, 2023
- Regenxbio Inc.
- Joseph Bruder
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ADENO-ASSOCIATED VIRUSES FOR OCULAR DELIVERY OF GENE THERAPY
- Publication number 20230381341
- Publication date Nov 30, 2023
- Regenxbio Inc.
- Joseph Bruder
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS FOR SUPRACHOROIDAL ADMINISTRATION SUCH AS FORMULATIONS...
- Publication number 20230372538
- Publication date Nov 23, 2023
- Regenxbio Inc.
- Jared Bee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT ADENO-ASSOCIATED VIRUSES FOR CNS OR MUSCLE DELIVERY
- Publication number 20230374541
- Publication date Nov 23, 2023
- Regenxbio Inc.
- Olivier Danos
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR OCULAR MANIFESTATIONS OF CLN2 DISEASE
- Publication number 20230364206
- Publication date Nov 16, 2023
- Regenxbio Inc.
- Christina Maria Ohnsman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOUNDS FOR USE IN THE TREATMENT OF EPILEPSY
- Publication number 20230323366
- Publication date Oct 12, 2023
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Céline BOILEAU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MICRODYSTROPHIN GENE THERAPY CONSTRUCTS AND USES THEREOF
- Publication number 20230270886
- Publication date Aug 31, 2023
- Regenxbio Inc.
- Chunping Qiao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING EPILEPSY
- Publication number 20230227829
- Publication date Jul 20, 2023
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Valérie CREPEL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ADENO-ASSOCIATED VIRUS FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS...
- Publication number 20230226225
- Publication date Jul 20, 2023
- Regents of the University of Minnesota
- R. Scott McIvor
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...
- Publication number 20230088992
- Publication date Mar 23, 2023
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS IVA
- Publication number 20230064077
- Publication date Mar 2, 2023
- Regenxbio Inc.
- Devin MCDOUGALD
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Treatment of Ocular Diseases with Fully-Human Post-Translationally...
- Publication number 20230057519
- Publication date Feb 23, 2023
- Regenxbio Inc.
- Curran Matthew SIMPSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED...
- Publication number 20230059395
- Publication date Feb 23, 2023
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE TREATMENT OF EPILEPSY
- Publication number 20230039652
- Publication date Feb 9, 2023
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Valérie CREPEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED NUCLEIC ACID REGULATORY ELEMENT AND METHODS OF USES THEREOF
- Publication number 20230042103
- Publication date Feb 9, 2023
- Regenxbio Inc.
- Chunping Qiao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF DIABETIC RETINOPATHY WITH FULLY-HUMAN POST-TRANSLATION...
- Publication number 20220280608
- Publication date Sep 8, 2022
- Regenxbio Inc.
- Stephen Joseph Pakola
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF SIZE EXCLUSION CHROMATOGRAPHY FOR THE CHARACTERIZATION O...
- Publication number 20220275358
- Publication date Sep 1, 2022
- Regenxbio Inc.
- Li ZHI
- G01 - MEASURING TESTING

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
98196277 - IDSYFUL
- Serial number 98196277
- Filing date Sep 25, 2023
- REGENXBIO Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98196308 - NAVSUNLI
- Serial number 98196308
- Filing date Sep 25, 2023
- REGENXBIO Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98196371 - GEMPSIIVO
- Serial number 98196371
- Filing date Sep 25, 2023
- REGENXBIO Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98196234 - XARMAPSII
- Serial number 98196234
- Filing date Sep 25, 2023
- REGENXBIO Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98123484 - REGENXBIO
- Serial number 98123484
- Filing date Aug 9, 2023
- REGENXBIO Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98123490
- Serial number 98123490
- Filing date Aug 9, 2023
- REGENXBIO Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98123485 - REGENXBIO
- Serial number 98123485
- Filing date Aug 9, 2023
- REGENXBIO Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97672137 - AFFINITY BEYOND
- Serial number 97672137
- Registration number 7368612
- Filing date Nov 10, 2022
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97672147 - AFFINITY BEYOND
- Serial number 97672147
- Registration number 7357017
- Filing date Nov 10, 2022
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97672155 - AFFINITY BEYOND
- Serial number 97672155
- Registration number 7357018
- Filing date Nov 10, 2022
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97526610 - CAMPSIITE
- Serial number 97526610
- Registration number 7070144
- Filing date Jul 29, 2022
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97436707 - NAVXCELL
- Serial number 97436707
- Registration number 7134753
- Filing date May 31, 2022
- REGENXBIO Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97436697 - NAVXPRESS
- Serial number 97436697
- Filing date May 31, 2022
- REGENXBIO Inc.
- 40 - Treatment of materials
Information Trademark
97125444 - AFFINITY
- Serial number 97125444
- Registration number 7263068
- Filing date Nov 15, 2021
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97125450 - AFFINITY-DUCHENNE
- Serial number 97125450
- Filing date Nov 15, 2021
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97125435 - AFFINITY DUCHENNE
- Serial number 97125435
- Registration number 7197150
- Filing date Nov 15, 2021
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90632317 - ELAAVATE
- Serial number 90632317
- Filing date Apr 8, 2021
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90530555 - VISTA
- Serial number 90530555
- Filing date Feb 16, 2021
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90530563 - GLIMPSE
- Serial number 90530563
- Filing date Feb 16, 2021
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90432225 - AAVIATION
- Serial number 90432225
- Filing date Dec 30, 2020
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90133768 - EMBARK
- Serial number 90133768
- Filing date Aug 24, 2020
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90133798 - NAAVIGATE
- Serial number 90133798
- Filing date Aug 24, 2020
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
90133732 - ASCENT
- Serial number 90133732
- Filing date Aug 24, 2020
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88863049 - AAVIATE
- Serial number 88863049
- Registration number 6274208
- Filing date Apr 7, 2020
- RegenxBio Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88863066 - CAMPSITE
- Serial number 88863066
- Filing date Apr 7, 2020
- RegenxBio Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88500159 - ALTITUDE
- Serial number 88500159
- Registration number 6631033
- Filing date Jul 3, 2019
- RegenxBio Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88500144 - ATMOSPHERE
- Serial number 88500144
- Registration number 6323051
- Filing date Jul 3, 2019
- RegenxBio Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88085174 - AAVIATION
- Serial number 88085174
- Filing date Aug 20, 2018
- RegenxBio Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
87200042 - CAMPSITE
- Serial number 87200042
- Filing date Oct 11, 2016
- REGENXBIO Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
87174818 - GENQUEST
- Serial number 87174818
- Filing date Sep 18, 2016
- Regenx Biosciences, LLC
- 42 - Scientific and technological services and research and design relating thereto

NIH Research Projectlast 12 months

processing...

Count: 5

Research Projects

Information Research Project
Genetically-delivered Bevacizumab for Treatment of Wet Age-Related...
- Application id 8451793
- Award notice date Jan 29, 2013
Information Research Project
AAV Mediated Gene Transfer to the CNS for MPS I
- Application id 8250741
- Award notice date Sep 21, 2012
Information Research Project
Novel Adeno-Associated Viral Therapy for Wet Age-Related Macular De...
- Application id 8392855
- Award notice date Aug 20, 2012
Information Research Project
Novel Adeno-Associated Viral Therapy for X-linked Retinitis Pigmentosa
- Application id 7927797
- Award notice date Jul 26, 2010
Information Research Project
Scalable Production of New Generation Adeno-Associated Virus Gene T...
- Application id 7801300
- Award notice date Jun 21, 2010

ReGenX Biosciences, LLC

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Treatment of mucopolysaccharidosis II with recombinant human iduron...

Treatment of mucopolysaccharidosis II with recombinant human iduron...

Methods to treat mucopolysaccharide type I or deficiency in alpha-L...

Patents Applicationslast 30 patents

METHOD OF PRODUCING A RECOMBINANT VIRUS PARTICLE

VECTORIZED ANTI-CGRP AND ANTI-CGRPR ANTIBODIES AND ADMINISTRATION T...

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...

INJECTION OF SINGLE-STRANDED OR SELF-COMPLEMENTARY ADENO-ASSOCIATED...

ADENO-ASSOCIATED VIRUS VECTOR PHARMACEUTICAL COMPOSITION AND METHODS

GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES

IMPROVED PRODUCTION OF RECOMBINANT POLYPEPTIDES AND VIRUSES

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...

TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED...

FORMULATIONS FOR SUPRACHOROIDAL ADMINISTRATION SUCH AS HIGH VISCOSI...

METHODS AND COMPOSITIONS FOR TREATING EPILEPSY

FORMULATIONS FOR SUPRACHOROIDAL ADMINISTRATION SUCH AS GEL FORMULAT...

VECTORIZED ANTI-TNF-ALPHA ANTIBODIES FOR OCULAR INDICATIONS

VECTORIZED FACTOR XII ANTIBODIES AND ADMINISTRATION THEREOF

ADENO-ASSOCIATED VIRUSES FOR OCULAR DELIVERY OF GENE THERAPY

FORMULATIONS FOR SUPRACHOROIDAL ADMINISTRATION SUCH AS FORMULATIONS...

RECOMBINANT ADENO-ASSOCIATED VIRUSES FOR CNS OR MUSCLE DELIVERY

GENE THERAPY FOR OCULAR MANIFESTATIONS OF CLN2 DISEASE

COMPOUNDS FOR USE IN THE TREATMENT OF EPILEPSY

MICRODYSTROPHIN GENE THERAPY CONSTRUCTS AND USES THEREOF

METHODS AND COMPOSITIONS FOR TREATING EPILEPSY

ADENO-ASSOCIATED VIRUS FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS...

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...

TREATMENT OF MUCOPOLYSACCHARIDOSIS IVA

Treatment of Ocular Diseases with Fully-Human Post-Translationally...

TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED...

METHODS FOR THE TREATMENT OF EPILEPSY

ENGINEERED NUCLEIC ACID REGULATORY ELEMENT AND METHODS OF USES THEREOF

TREATMENT OF DIABETIC RETINOPATHY WITH FULLY-HUMAN POST-TRANSLATION...

METHODS OF SIZE EXCLUSION CHROMATOGRAPHY FOR THE CHARACTERIZATION O...

Trademarklast 30 trademarks

98196277 - IDSYFUL

98196308 - NAVSUNLI

98196371 - GEMPSIIVO

98196234 - XARMAPSII

98123484 - REGENXBIO

98123490

98123485 - REGENXBIO

97672137 - AFFINITY BEYOND

97672147 - AFFINITY BEYOND

97672155 - AFFINITY BEYOND

97526610 - CAMPSIITE

97436707 - NAVXCELL

97436697 - NAVXPRESS

97125444 - AFFINITY

97125450 - AFFINITY-DUCHENNE

97125435 - AFFINITY DUCHENNE

90632317 - ELAAVATE

90530555 - VISTA

90530563 - GLIMPSE

90432225 - AAVIATION

90133768 - EMBARK

90133798 - NAAVIGATE

90133732 - ASCENT

88863049 - AAVIATE

88863066 - CAMPSITE

88500159 - ALTITUDE

88500144 - ATMOSPHERE

88085174 - AAVIATION

87200042 - CAMPSITE

87174818 - GENQUEST

NIH Research Projectlast 12 months

Research Projects

Genetically-delivered Bevacizumab for Treatment of Wet Age-Related...

AAV Mediated Gene Transfer to the CNS for MPS I

Novel Adeno-Associated Viral Therapy for Wet Age-Related Macular De...

Novel Adeno-Associated Viral Therapy for X-linked Retinitis Pigmentosa

Scalable Production of New Generation Adeno-Associated Virus Gene T...